Northern Trust’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.49M | Buy |
565,286
+21,793
| +4% | +$390K | ﹤0.01% | 2107 |
|
|
2025
Q4 | $8.71M | Sell |
543,493
-34,240
| -6% | -$510K | ﹤0.01% | 2156 |
|
|
2025
Q3 | $7.14M | Sell |
577,733
-30,626
| -5% | -$359K | ﹤0.01% | 2302 |
|
|
2025
Q2 | $7.01M | Buy |
608,359
+77,374
| +15% | +$918K | ﹤0.01% | 2269 |
|
|
2025
Q1 | $7.96M | Sell |
530,985
-46,767
| -8% | -$783K | ﹤0.01% | 2176 |
|
|
2024
Q4 | $10M | Buy |
577,752
+78,173
| +16% | +$1.51M | ﹤0.01% | 2121 |
|
|
2024
Q3 | $9.26M | Sell |
499,579
-515
| -0.1% | -$10.3K | ﹤0.01% | 2108 |
|
|
2024
Q2 | $10.1M | Sell |
500,094
-7,171
| -1% | -$127K | ﹤0.01% | 1992 |
|
|
2024
Q1 | $8.66M | Buy |
507,265
+12,929
| +3% | +$203K | ﹤0.01% | 2128 |
|
|
2023
Q4 | $8.73M | Sell |
494,336
-44,795
| -8% | -$903K | ﹤0.01% | 2157 |
|
|
2023
Q3 | $12.9M | Buy |
539,131
+3,339
| +0.6% | +$82K | ﹤0.01% | 1830 |
|
|
2023
Q2 | $12.5M | Buy |
535,792
+322,210
| +151% | +$7.29M | ﹤0.01% | 1896 |
|
|
2023
Q1 | $4.71M | Buy |
213,582
+10,274
| +5% | +$240K | ﹤0.01% | 2504 |
|
|
2022
Q4 | $4.12M | Buy |
203,308
+11,392
| +6% | +$221K | ﹤0.01% | 2604 |
|
|
2022
Q3 | $2.59M | Buy |
191,916
+963
| +0.5% | +$16.2K | ﹤0.01% | 2875 |
|
|
2022
Q2 | $3.78M | Buy |
190,953
+23,688
| +14% | +$629K | ﹤0.01% | 2679 |
|
|
2022
Q1 | $5.29M | Sell |
167,265
-699
| -0.4% | -$19.6K | ﹤0.01% | 2555 |
|
|
2021
Q4 | $3.75M | Sell |
167,964
-4,730
| -3% | -$123K | ﹤0.01% | 2877 |
|
|
2021
Q3 | $4.79M | Buy |
172,694
+7,487
| +5% | +$228K | ﹤0.01% | 2760 |
|
|
2021
Q2 | $6.43M | Buy |
165,207
+1,139
| +0.7% | +$40.8K | ﹤0.01% | 2688 |
|
|
2021
Q1 | $4.72M | Buy |
164,068
+27,278
| +20% | +$932K | ﹤0.01% | 2783 |
|
|
2020
Q4 | $3.63M | Sell |
136,790
-13,401
| -9% | -$274K | ﹤0.01% | 2858 |
|
|
2020
Q3 | $2.29M | Sell |
150,191
-60,955
| -29% | -$1.28M | ﹤0.01% | 2995 |
|
|
2020
Q2 | $4.29M | Sell |
211,146
-84,719
| -29% | -$1.52M | ﹤0.01% | 2613 |
|
|
2020
Q1 | $3.06M | Sell |
295,865
-19,359
| -6% | -$541K | ﹤0.01% | 2602 |
|
|
2019
Q4 | $11.9M | Sell |
315,224
-51,235
| -14% | -$2.3M | ﹤0.01% | 2070 |
|
|
2019
Q3 | $17.1M | Buy |
366,459
+33,004
| +10% | +$1.53M | ﹤0.01% | 1800 |
|
|
2019
Q2 | $17.4M | Sell |
333,455
-95,563
| -22% | -$5.61M | ﹤0.01% | 1785 |
|
|
2019
Q1 | $29.6M | Sell |
429,018
-56,894
| -12% | -$3.81M | 0.01% | 1377 |
|
|
2018
Q4 | $29M | Sell |
485,912
-11,291
| -2% | -$974K | 0.01% | 1276 |
|
|
2018
Q3 | $57.6M | Buy |
497,203
+13,196
| +3% | +$1.49M | 0.01% | 895 |
|
|
2018
Q2 | $61.1M | Buy |
484,007
+9,341
| +2% | +$1.14M | 0.02% | 829 |
|
|
2018
Q1 | $51.4M | Buy |
474,666
+11,777
| +3% | +$1.3M | 0.01% | 978 |
|
|
2017
Q4 | $50.7M | Sell |
462,889
-28,758
| -6% | -$2.87M | 0.01% | 968 |
|
|
2017
Q3 | $48.5M | Buy |
491,647
+126,573
| +35% | +$12.3M | 0.01% | 970 |
|
|
2017
Q2 | $37M | Buy |
365,074
+55,236
| +18% | +$5.96M | 0.01% | 1170 |
|
|
2017
Q1 | $35.8M | Buy |
309,838
+14,122
| +5% | +$1.64M | 0.01% | 1177 |
|
|
2016
Q4 | $35.5M | Sell |
295,716
-347,527
| -54% | -$38.5M | 0.01% | 1151 |
|
|
2016
Q3 | $72.3M | Buy |
643,243
+20,021
| +3% | +$2.31M | 0.02% | 635 |
|
|
2016
Q2 | $77.2M | Buy |
623,222
+46,332
| +8% | +$5.59M | 0.03% | 590 |
|
|
2016
Q1 | $60.1M | Buy |
576,890
+9,229
| +2% | +$959K | 0.02% | 694 |
|
|
2015
Q4 | $61.7M | Buy |
567,661
+142,268
| +33% | +$16.3M | 0.02% | 669 |
|
|
2015
Q3 | $42.5M | Buy |
425,393
+12,204
| +3% | +$1.33M | 0.01% | 924 |
|
|
2015
Q2 | $47.1M | Sell |
413,189
-18,708
| -4% | -$2.27M | 0.01% | 899 |
|
|
2015
Q1 | $45.1M | Buy |
431,897
+87,175
| +25% | +$9.29M | 0.01% | 949 |
|
|
2014
Q4 | $41.5M | Sell |
344,722
-4,450
| -1% | -$585K | 0.01% | 973 |
|
|
2014
Q3 | $51.1M | Buy |
349,172
+118,044
| +51% | +$18.2M | 0.02% | 780 |
|
|
2014
Q2 | $38.6M | Sell |
231,128
-112,231
| -33% | -$20M | 0.01% | 988 |
|
|
2014
Q1 | $68.1M | Buy |
343,359
+123,951
| +56% | +$23.4M | 0.02% | 642 |
|
|
2013
Q4 | $41.9M | Buy |
219,408
+7,574
| +4% | +$1.41M | 0.01% | 902 |
|
|
2013
Q3 | $35.8M | Sell |
211,834
-10,969
| -5% | -$1.7M | 0.01% | 936 |
|
|
2013
Q2 | $33.8M | Buy |
+222,803
| New | +$31.6M | 0.01% | 944 |
|
Other funds holding CLB
AI
DGI
CAMG
VCM
VPM
Northern Trust's CLB Position: Q1 2026 in Review
Northern Trust increased its Core Laboratories (CLB) stake by 4% in Q1 2026, buying an estimated $390K and bringing the position to 565,286 shares worth $9.49M. The position accounts for ﹤0.01% of the portfolio, ranked #2107.
Northern Trust first reported a position in CLB in Q2 2013 and has held it in 52 quarters since. The position peaked at $77.2M in Q2 2016. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.
- Northern Trust held 565,286 shares of Core Laboratories worth $9.49M as of Q1 2026.
- Northern Trust bought 21,793 Core Laboratories shares in Q1 2026, an estimated $390K.
- Core Laboratories made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #2107 holding.
- Northern Trust first reported a position in Core Laboratories in Q2 2013 and has held it in 52 quarters since.
- Northern Trust's Core Laboratories position peaked at $77.2M in Q2 2016.
- 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.